Status:
COMPLETED
Lidocaine and Pain Management in First Trimester Abortions
Lead Sponsor:
Oregon Health and Science University
Conditions:
Pain
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine the effect of lidocaine (a numbing medication) inside the uterus on patient pain during an early abortion, compared to the paracervical block (lidocaine injecte...
Detailed Description
The Investigators intend to conduct a randomized, patient-blinded control trial at Oregon Health and Science University and Planned Parenthood of the Columbia Willamette. Women will be approached abou...
Eligibility Criteria
Inclusion
- Good general health
- Age\>18years
- English speaking
- Voluntarily requesting pregnancy termination
- Have an estimated gestation of up to 76 days since the first day of the preceding menstrual period
- Confirmed by ultrasound
- Be able and willing to sign an informed consent
- Agree to the terms of the study
- All patients must be premedicated with Ibuprofen and Valium (per clinic protocols)
Exclusion
- Significant physical or mental health condition
- A gestational age of 77 days or more
- Adnexal mass or tenderness on pelvic exam consistent with pelvic inflammatory disease
- Patients who require or request IV/intramuscular sedation
- Patients who refuse Ibuprofen, Valium and/or paracervical blocks
- Patients allergic to lidocaine
- Patients with known hepatic disease
- Patients weighing less than 100 lbs
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00613821
Start Date
September 1 2007
End Date
May 1 2008
Last Update
July 31 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Planned Parenthood of the Columbia Willamette
Portland, Oregon, United States, 96822
2
Oregon Health and Science University
Portland, Oregon, United States, 97239